Intellectual Property
& Patents

GreenWay Herbal Products, LLC is the owner and licensor of a growing portfolio of issued and pending intellectual property focused on cannabinoid compositions and methods of use. Our research-driven approach is centered on advancing cannabinoid science with the long-term objective of developing regulated pharmaceutical and therapeutic applications.

One of GreenWay’s wholly owned subsidiaries, GreenWay Tanasi, LLC, operates as the exclusive licensee of select GreenWay intellectual property. Tanasi™ serves as a consumer-facing brand built around our patented equal molar mixture of cannabidiol and cannabidiolic acid (1:1 CBD+CBDA). The Tanasi brand was launched in 2019 as a strategic vehicle to responsibly commercialize the formulation, generate real-world usage data, and support broader research and development efforts.

Since launch, Tanasi products have been consistently adopted through direct-to-consumer purchases, subscriptions, and repeat purchases. Feedback from customers has reinforced a core scientific insight underlying our patent strategy: while cannabidiol alone may be effective, the 1-to-1 cannabidiol and cannabidiolic acid composition demonstrates meaningfully improved performance, supporting the rationale for continued research and development of this formulation.

University Collaboration & Patent Development

GreenWay’s intellectual property portfolio originates from a university research collaboration established in 2016. In 2019, research from this collaboration resulted in the filing of a patent application by Middle Tennessee State University (MTSU). The intellectual property was later assigned to GreenWay Herbal Products, LLC in 2022, reflecting GreenWay’s role as the long-term steward and developer of the technology.

Cannabinoid Compositions and Methods of Use

Issued Patents

• United Kingdom (2023)

  • GB 2597163

  • GB 2614634

• United States (2025)

  • US 12,496,307

Pending Patent Applications

• Canada (CA 3132856)

• European Union (EP 3962296)

• Israel (IL 318621)

• Thailand

Additional Patent Applications

• Cannabinoid and omega fatty acid compositions and methods of use

Looking Forward

GreenWay Herbal Products continues to invest in cannabinoid research with the intent to expand its intellectual property estate and, subject to regulatory pathways, pursue future clinical development opportunities. Our strategy balances near-term commercialization through licensed consumer brands with long-term pharmaceutical and therapeutic innovation grounded in defensible science and issued patents.

[updated: 12/18/2025]